EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells

PLoS Pathogens

Volumn 12, Issue 1, 2016, Pages

  Kalchschmidt, Jens S ^a   Gillman, Adam C T ^a   Paschos, Kostas ^a   Bazot, Quentin ^a   Kempkes, Bettina ^b   Allday, Martin J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR NUCLEAR PROTEIN EBNA3C; NOTCH RECEPTOR; RECOMBINATION SIGNAL BINDING PROTEIN J; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; CHROMATIN; EBNA-3C, EPSTEIN-BARR VIRUS; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; RBPJ PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION ASSAY; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENE REPRESSION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; HOST PARASITE INTERACTION; VIROLOGY;

B-LYMPHOCYTES; CELLS, CULTURED; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84956815097     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005383     Document Type: Article

References (99)

1. Young LS, Rickinson AB, Epstein–Barr virus: 40 years on. Nat Rev Cancer. 2004;4: 757–768. doi: 10.1038/nrc1452 15510157
2. Kutok JL, Wang F, Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol. 2006;1: 375–404. doi: 10.1146/annurev.pathol.1.110304.100209 18039120
3. Davies ML, Xu S, Lyons-Weiler J, Rosendorff A, Webber SA, Wasil LR, et al. Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines. Virology. 2010;400: 53–67. doi: 10.1016/j.virol.2010.01.002 20153012
4. Touitou R, O'Nions J, Heaney J, Allday MJ, Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. J Gen Virol. 2005;86: 1269–1277. doi: 10.1099/vir.0.80763–0 15831937
5. Hertle ML, Popp C, Petermann S, Maier S, Kremmer E, Lang R, et al. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog. 2009;5: e1000506. doi: 10.1371/journal.ppat.1000506 19578441
6. White RE, Kremmer E, Allday MJ, Masucci MG, Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification. PLoS ONE. 2010;5: e13979. doi: 10.1371/journal.pone.0013979.t001 21085583
7. Zhao B, Mar JC, Maruo S, Lee S, Gewurz BE, Johannsen E, et al. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines. Proc Natl Acad Sci USA. 2011;108: 337–342. doi: 10.1073/pnas.1017419108 21173222
8. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, et al. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. Journal of Virology. 1995;69: 3108–3116. 7707539
9. Robertson ES, Lin J, Kieff E, The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). Journal of Virology. 1996;70: 3068–3074. 8627785
10. Krauer KG, Kienzle N, Young DB, Sculley TB, Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes. Virology. 1996;226: 346–353. doi: 10.1006/viro.1996.0662 8955054
11. Zhao B, Marshall DR, Sample CE, A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. Journal of Virology. 1996;70: 4228–4236. 8676443
12. Marshall D, Sample C, Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. Journal of Virology. 1995;69: 3624–3630. 7745710
13. Bray SJ, Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. Nature Publishing Group; 2006;7: 678–689. doi: 10.1038/nrm2009 16921404
14. Hori K, Sen A, Artavanis-Tsakonas S, Notch signaling at a glance. J Cell Sci. The Company of Biologists Ltd; 2013;126: 2135–2140. doi: 10.1242/jcs.127308 23729744
15. Olave I, Reinberg D, Vales LD, The mammalian transcriptional repressor RBP (CBF1) targets TFIID and TFIIA to prevent activated transcription. Genes Dev. Cold Spring Harbor Laboratory Press; 1998;12: 1621–1637. 9620850
16. Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, et al. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. Cold Spring Harbor Laboratory Press; 1998;12: 2269–2277. 9694793
17. Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD, CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci USA. National Academy of Sciences; 1999;96: 23–28. 9874765
18. Oswald F, Kostezka U, Astrahantseff K, Bourteele S, Dillinger K, Zechner U, et al. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. EMBO J. European Molecular Biology Organization; 2002;21: 5417–5426. doi: 10.1093/emboj/cdf549 12374742
19. Oswald F, Winkler M, Cao Y, Astrahantseff K, Bourteele S, Knöchel W, et al. RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. Mol Cell Biol. American Society for Microbiology; 2005;25: 10379–10390. doi: 10.1128/MCB.25.23.10379–10390.2005 16287852
20. Taniguchi Y, Furukawa T, Tun T, Han H, Honjo T, LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein. Mol Cell Biol. American Society for Microbiology (ASM); 1998;18: 644–654. 9418910
21. Mumm JS, Kopan R, Notch signaling: from the outside in. Dev Biol. 2000;228: 151–165. doi: 10.1006/dbio.2000.9960 11112321
22. Fortini ME, Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol. Nature Publishing Group; 2002;3: 673–684. doi: 10.1038/nrm910 12209127
23. Selkoe D, Kopan R, Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. Annual Reviews 4139 El Camino Way, P.O. Box 10139, Palo Alto, CA 94303–0139, USA; 2003;26: 565–597. doi: 10.1146/annurev.neuro.26.041002.131334 12730322
24. Tamura K, Taniguchi Y, Minoguchi S, Sakai T, Tun T, Furukawa T, et al. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H). Curr Biol. 1995;5: 1416–1423. 8749394
25. Roehl H, Kimble J, Control of cell fate in C. elegans by a GLP-1 peptide consisting primarily of ankyrin repeats. Nature. Nature Publishing Group; 1993;364: 632–635. doi: 10.1038/364632a0 8350921
26. Kato H, Taniguchi Y, Kurooka H, Minoguchi S, Sakai T, Nomura-Okazaki S, et al. Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. Development. 1997;124: 4133–4141. 9374409
27. Kurooka H, Kuroda K, Honjo T, Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region. Nucleic Acids Research. Oxford University Press; 1998;26: 5448–5455. 9826771
28. Petcherski AG, Kimble J, LAG-3 is a putative transcriptional activator in the C. elegans Notch pathway. Nature. Nature Publishing Group; 2000;405: 364–368. doi: 10.1038/35012645
29. Petcherski AG, Kimble J, Mastermind is a putative activator for Notch. Curr Biol. 2000;10: R471–3. 10898989
30. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD, MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet. 2000;26: 484–489. doi: 10.1038/82644 11101851
31. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E, The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci USA. 1994;91: 7568–7572. 8052621
32. Henkel T, Ling PD, Hayward SD, Peterson MG, Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science. 1994;265: 92–95. 8016657
33. Waltzer L, Logeat F, Brou C, Israel A, Sergeant A, Manet E, The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J. European Molecular Biology Organization; 1994;13: 5633–5638. 7988560
34. Zimber-Strobl U, Strobl LJ, Meitinger C, Hinrichs R, Sakai T, Furukawa T, et al. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J. European Molecular Biology Organization; 1994;13: 4973–4982. 7957063
35. Zimber-Strobl U, Strobl LJ, EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol. 2001;11: 423–434. doi: 10.1006/scbi.2001.0409 11669604
36. Johannsen E, Miller CL, Grossman SR, Kieff E, EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. Journal of Virology. American Society for Microbiology (ASM); 1996;70: 4179–4183. 8648764
37. Waltzer L, Perricaudet M, Sergeant A, Manet E, Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. Journal of Virology. 1996;70: 5909–5915. 8709211
38. Le Roux A, Kerdiles B, Walls D, Dedieu JF, Perricaudet M, The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology. 1994;205: 596–602. doi: 10.1006/viro.1994.1687 7975264
39. Radkov SA, Bain M, Farrell PJ, West M, Rowe M, Allday MJ, Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. Journal of Virology. 1997;71: 8552–8562. 9343213
40. Maruo S, Wu Y, Ito T, Kanda T, Kieff ED, Takada K, Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc Natl Acad Sci USA. 2009;106: 4419–4424. doi: 10.1073/pnas.0813134106 19237563
41. Lee S, Sakakibara S, Maruo S, Zhao B, Calderwood MA, Holthaus AM, et al. Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. Journal of Virology. American Society for Microbiology; 2009;83: 12368–12377. doi: 10.1128/JVI.01403-09 19776126
42. Calderwood MA, Lee S, Holthaus AM, Blacklow SC, Kieff E, Johannsen E, Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth. Virology. 2011;414: 19–25. doi: 10.1016/j.virol.2011.02.018 21440926
43. Hayward SD, Viral interactions with the Notch pathway. Semin Cancer Biol. 2004;14: 387–396. doi: 10.1016/j.semcancer.2004.04.018 15288264
44. Hayward SD, Liu J, Fujimuro M, Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses. Sci STKE. Science Signaling; 2006;2006: re4–re4. doi: 10.1126/stke.3352006re4 16705130
45. Harth-Hertle ML, Scholz BA, Erhard F, Glaser LV, Dölken L, Zimmer R, et al. Inactivation of Intergenic Enhancers by EBNA3A Initiates and Maintains Polycomb Signatures across a Chromatin Domain Encoding CXCL10 and CXCL9. PLoS Pathog. 2013;9: e1003638. doi: 10.1371/journal.ppat.1003638 24068939
46. Bain M, Watson RJ, Farrell PJ, Allday MJ, Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. Journal of Virology. 1996;70: 2481–2489. 8642676
47. Bourillot PY, Waltzer L, Sergeant A, Manet E, Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. J Gen Virol. 1998;79 (Pt 2): 363–370. 9472621
48. Radkov SA, Touitou R, Brehm A, Rowe M, West M, Kouzarides T, et al. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. Journal of Virology. 1999;73: 5688–5697. 10364319
49. Knight JS, Lan K, Subramanian C, Robertson ES, Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. Journal of Virology. 2003;77: 4261–4272. 12634383
50. Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ, Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. Journal of Virology. American Society for Microbiology; 2001;75: 7749–7755. doi: 10.1128/JVI.75.16.7749–7755.2001 11462050
51. McClellan MJ, Khasnis S, Wood CD, Palermo RD, Schlick SN, Kanhere AS, et al. Downregulation of Integrin Receptor-Signaling Genes by Epstein-Barr Virus EBNA 3C via Promoter-Proximal and -Distal Binding Elements. Journal of Virology. 2012;86: 5165–5178. doi: 10.1128/JVI.07161-11 22357270
52. Skalska L, White RE, Parker GA, Sinclair AJ, Paschos K, Allday MJ, Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog. 2013;9: e1003187. doi: 10.1371/journal.ppat.1003187 23436997
53. McClellan MJ, Wood CD, Ojeniyi O, Cooper TJ, Kanhere A, Arvey A, et al. Modulation of enhancer looping and differential gene targeting by epstein-barr virus transcription factors directs cellular reprogramming. PLoS Pathog. 2013;9: e1003636. doi: 10.1371/journal.ppat.1003636 24068937
54. Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ, Two Epstein–Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene. 2007;27: 421–433. doi: 10.1038/sj.onc.1210668 17653091
55. Skalska L, White RE, Allday MJ, Speck SH, Epigenetic Repression of p16INK4A by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog. 2010;6: e1000951. doi: 10.1371/journal.ppat.1000951.g010 20548956
56. Bazot Q, Paschos K, Skalska L, Kalchschmidt JS, Parker GA, Allday MJ, Flemington EK, Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2. PLoS Pathog. Public Library of Science; 2015;11: e1005031. doi: 10.1371/journal.ppat.1005031 26153983
57. Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ, BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Research. 2012;40: 7233–7246. doi: 10.1093/nar/gks391 22584624
58. Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, Cohen MM, et al. Establishment in continuous culture of a new type of lymphocyte from a “Burkitt like” malignant lymphoma (line D.G.-75). Int J Cancer. 1977;19: 27–33. 188769
59. Allday MJ, Crawford DH, Thomas JA, Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. J Gen Virol. 1993;74 (Pt 3): 361–369. 8383171
60. Maier S, Santak M, Mantik A, Grabusic K, Kremmer E, Hammerschmidt W, et al. A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent. Journal of Virology. American Society for Microbiology; 2005;79: 8784–8792. doi: 10.1128/JVI.79.14.8784–8792.2005 15994772
61. Yatim A, Benne C, Sobhian B, Laurent-Chabalier S, Deas O, Judde J-G, et al. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell. 2012;48: 445–458. doi: 10.1016/j.molcel.2012.08.022 23022380
62. Krejcí A, Bray S, Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev. 2007;21: 1322–1327. doi: 10.1101/gad.424607 17545467
63. Castel D, Mourikis P, Bartels SJJ, Brinkman AB, Tajbakhsh S, Stunnenberg HG, Dynamic binding of RBPJ is determined by Notch signaling status. Genes Dev. Cold Spring Harbor Lab; 2013;27: 1059–1071. doi: 10.1101/gad.211912.112 23651858
64. Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E, EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci USA. National Acad Sciences; 2011;108: 7808–7813. doi: 10.1073/pnas.1104991108 21518914
65. Messeguer X, Escudero R, Farré D, Núñez O, Martínez J, Albà MM, PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18: 333–334. 11847087
66. Farré D, Roset R, Huerta M, Adsuara JE, Roselló L, Albà MM, et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Research. Oxford University Press; 2003;31: 3651–3653. 12824386
67. Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT, et al. Epstein-Barr Virus Nuclear Antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc Natl Acad Sci USA. 2013. doi: 10.1073/pnas.1321704111
68. Schmidt SCS, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, et al. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Proc Natl Acad Sci USA. National Acad Sciences; 2014;: 201422580. doi: 10.1073/pnas.1422580112
69. Jin Y, He Z, Liang D, Zhang Q, Zhang H, Deng Q, et al. Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. Journal of Virology. American Society for Microbiology; 2012;86: 4956–4969. doi: 10.1128/JVI.06788-11 22379075
70. Lake RJ, Tsai P-F, Choi I, Won K-J, Fan H-Y, Fortini M, RBPJ, the major transcriptional effector of Notch signaling, remains associated with chromatin throughout mitosis, suggesting a role in mitotic bookmarking. PLoS Genet. Public Library of Science; 2014;10: e1004204. doi: 10.1371/journal.pgen.1004204
71. Haery L, Thompson RC, Gilmore TD, Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy. Genes Cancer. Impact Journals, LLC; 2015;6: 184–213. 26124919
72. Iwase S, Lan F, Bayliss P, la Torre-Ubieta de L, Huarte M, Qi HH, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell. 2007;128: 1077–1088. doi: 10.1016/j.cell.2007.02.017 17320160
73. Christensen J, Agger K, Cloos PAC, Pasini D, Rose S, Sennels L, et al. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell. 2007;128: 1063–1076. doi: 10.1016/j.cell.2007.02.003 17320161
74. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell. 2007;128: 889–900. doi: 10.1016/j.cell.2007.02.013 17320163
75. Lee MG, Norman J, Shilatifard A, Shiekhattar R, Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell. 2007;128: 877–887. doi: 10.1016/j.cell.2007.02.004 17320162
76. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature. Nature Publishing Group; 2007;447: 601–605. doi: 10.1038/nature05823
77. Kooistra SM, Helin K, Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol. Nature Publishing Group; 2012;13: 297–311. doi: 10.1038/nrm3327 22473470
78. Hayakawa T, Ohtani Y, Hayakawa N, Shinmyozu K, Saito M, Ishikawa F, et al. RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. Genes Cells. Blackwell Publishing Inc; 2007;12: 811–826. doi: 10.1111/j.1365-2443.2007.01089.x
79. Hayakawa T, Nakayama J-I, Physiological roles of class I HDAC complex and histone demethylase. J Biomed Biotechnol. Hindawi Publishing Corporation; 2011;2011: 129383–10. doi: 10.1155/2011/129383 21049000
80. Schoeftner S, Sengupta AK, Kubicek S, Mechtler K, Spahn L, Koseki H, et al. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J. EMBO Press; 2006;25: 3110–3122. doi: 10.1038/sj.emboj.7601187 16763550
81. Pasini D, Bracken AP, Hansen JB, Capillo M, Helin K, The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol. American Society for Microbiology; 2007;27: 3769–3779. doi: 10.1128/MCB.01432-06 17339329
82. Tavares L, Dimitrova E, Oxley D, Webster J, Poot R, Demmers J, et al. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell. 2012;148: 664–678. doi: 10.1016/j.cell.2011.12.029 22325148
83. Yu M, Mazor T, Huang H, Huang H-T, Kathrein KL, Woo AJ, et al. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell. 2012;45: 330–343. doi: 10.1016/j.molcel.2011.11.032 22325351
84. Blackledge NP, Farcas AM, Kondo T, King HW, McGouran JF, Hanssen LLP, et al. Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation. Cell. 2014;157: 1445–1459. doi: 10.1016/j.cell.2014.05.004 24856970
85. Cooper S, Dienstbier M, Hassan R, Schermelleh L, Sharif J, Blackledge NP, et al. Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitment. Cell Rep. 2014;7: 1456–1470. doi: 10.1016/j.celrep.2014.04.012 24857660
86. Kalb R, Latwiel S, Baymaz HI, Jansen PWTC, Müller CW, Vermeulen M, et al. Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression. Nat Struct Mol Biol. Nature Publishing Group; 2014;21: 569–571. doi: 10.1038/nsmb.2833 24837194
87. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125: 301–313. doi: 10.1016/j.cell.2006.02.043 16630818
88. Tanay A, O'Donnell AH, Damelin M, Bestor TH, Hyperconserved CpG domains underlie Polycomb-binding sites. Proc Natl Acad Sci USA. National Acad Sciences; 2007;104: 5521–5526. doi: 10.1073/pnas.0609746104 17376869
89. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, van Steensel B, et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. Public Library of Science; 2008;4: e1000242. doi: 10.1371/journal.pgen.1000242
90. Mendenhall EM, Koche RP, Truong T, Zhou VW, Issac B, Chi AS, Madhani HD, et al. GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet. Public Library of Science; 2010;6: e1001244. doi: 10.1371/journal.pgen.1001244 21170310
91. Lanzuolo C, Roure V, Dekker J, Bantignies F, Orlando V, Polycomb response elements mediate the formation of chromosome higher-order structures in the bithorax complex. Nat Cell Biol. Nature Publishing Group; 2007;9: 1167–1174. doi: 10.1038/ncb1637 17828248
92. Tiwari VK, McGarvey KM, Licchesi JDF, Ohm JE, Herman JG, Schübeler D, Becker PB, et al. PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol. Public Library of Science; 2008;6: 2911–2927. doi: 10.1371/journal.pbio.0060306 19053175
93. Tiwari VK, Cope L, McGarvey KM, Ohm JE, Baylin SB, A novel 6C assay uncovers Polycomb-mediated higher order chromatin conformations. Genome Res. Cold Spring Harbor Lab; 2008;18: 1171–1179. doi: 10.1101/gr.073452.107 18502945
94. Cheutin T, Cavalli G, Polycomb silencing: from linear chromatin domains to 3D chromosome folding. Curr Opin Genet Dev. 2014;25: 30–37. doi: 10.1016/j.gde.2013.11.016 24434548
95. Zhao B, Zou J, Wang H, Johannsen E, Peng C-W, Quackenbush J, et al. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci USA. National Acad Sciences; 2011;108: 14902–14907. doi: 10.1073/pnas.1108892108 21746931
96. Hickabottom M, Parker GA, Freemont P, Crook T, Allday MJ, Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J Biol Chem. 2002;277: 47197–47204. doi: 10.1074/jbc.M208116200 12372828
97. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W, Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci USA. 1998;95: 8245–8250. 9653172
98. White RE, Calderwood MA, Whitehouse A, Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. J Gen Virol. 2003;84: 3393–3403. 14645920
99. Wade-Martins R, Frampton J, James MR, Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. Nucleic Acids Research. Oxford University Press; 1999;27: 1674–1682. 10075999